Outpatient studies:
CTBRI also conducts a wide variety of outpatient drug development studies these include drugs used for drug resistant TB drug sensitive TB, HIV, other infectious diseases and vaccination studies for tuberculosis and viral illnesses. These studies are conducted in our state-of-the-art outpatient unit on the lower ground floor and there is a full transport network in place to move participant safely between their clinics and the facility.